Share the wealth.

Of knowledge. While slowly improving, over half of industry-sponsored trials resulting in FDA approval of oncologic drugs over the past decade have failed to participate in data sharing, which, sure, helps hoard profits but does nothing to foster innovation. | Modi, JAMA Oncol 2022